Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Aug 26;8(9):78.
doi: 10.3390/cancers8090078.

Aberrant Wnt Signaling in Leukemia

Affiliations
Review

Aberrant Wnt Signaling in Leukemia

Frank J T Staal et al. Cancers (Basel). .

Abstract

The Wnt signaling pathway is essential in the development and homeostasis of blood and immune cells, but its exact role is still controversial and is the subject of intense research. The malignant counterpart of normal hematopoietic cells, leukemic (stem) cells, have hijacked the Wnt pathway for their self-renewal and proliferation. Here we review the multiple ways dysregulated Wnt signaling can contribute to leukemogenesis, both cell autonomously as well as by changes in the microenvironment.

Keywords: ALL; AML; CLL; CML; Wnt signaling; leukemia; leukemic stem cell; pathogenesis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Normal human hematopoiesis. All blood cells are derived from a rare population of stem cells, which give rise to more lineage restricted progenitor cells that largely lack self-renewal. T-lymphocytes develop in the specialized microenvironment of the thymus. Wnt signaling is highest in the thymus, but also present in HSCs, CMP, CLP, and at low levels in pro B cells. The intensity of the blue color indicates the levels of Wnt signaling in the subpopulations depicted. All mature blood cells lack Wnt signaling, except a significant fraction of peripheral T cells. Data from Wnt signaling levels are derived from [15].
Figure 2
Figure 2
Leukemia development in humans. Leukemias are shown as malignant counterparts from normal hematopoietic cells. The figure is drawn to stress the similarities, not differences. For details on Wnt signaling in the various types of leukemia, see the main text.

Similar articles

Cited by

References

    1. Orkin S.H., Zon L.I. Hematopoiesis: An evolving paradigm for stem cell biology. Cell. 2008;132:631–644. doi: 10.1016/j.cell.2008.01.025. - DOI - PMC - PubMed
    1. Blank U., Karlsson G., Karlsson S. Signaling pathways governing stem-cell fate. Blood. 2008;111:492–503. doi: 10.1182/blood-2007-07-075168. - DOI - PubMed
    1. Staal F.J., Baum C., Cowan C., Dzierzak E., Hacein-Bey-Abina S., Karlsson S., Lapidot T., Lemischka I., Mendez-Ferrer S., Mikkers H., et al. Stem cell self-renewal: Lessons from bone marrow, gut and IPS toward clinical applications. Leukemia. 2011;25:1095–1102. doi: 10.1038/leu.2011.52. - DOI - PubMed
    1. Luis T.C., Killmann N.M., Staal F.J. Signal transduction pathways regulating hematopoietic stem cell biology: Introduction to a series of spotlight reviews. Leukemia. 2012;26:86–90. doi: 10.1038/leu.2011.260. - DOI - PubMed
    1. Eaves C.J. Hematopoietic stem cells: Concepts, definitions, and the new reality. Blood. 2015;125:2605–2613. doi: 10.1182/blood-2014-12-570200. - DOI - PMC - PubMed

LinkOut - more resources